✦ LIBER ✦

Treatment of chronic hepatitis C in patients who have failed to respond to IFN or IFN and ribavirin combination therapy

✍ Scribed by Mazen Alsatie; Paul Y. Kwo

Book ID: 107540362
Publisher: Current Science Inc.
Year: 2003
Tongue: English
Weight: 386 KB
Volume: 2
Category: Article
ISSN: 1540-3416
DOI: 10.1007/s11901-003-0012-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis C patient

Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon α — hype or hope?

✍ Wolfgang Vogel 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 440 KB

Management of chronic hepatitis C patien

Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin

✍ D. T. Dieterich; M. Rizzetto; M. P. Manns 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB

Current antiviral combination therapy fo

Current antiviral combination therapy for chronic hepatitis C patients who failed to interferon alfa-based treatment

✍ M. Trapero-Marugán; J. Mendoza; J. A. Moreno Monteagudo; M. Chaparro; L. García- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

Retrospective, observational, multicentr

Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study

✍ F. Morisco; T. Stroffolini; E. Medda; D. C. Amoruso; P. L. Almasio; E. Villa; M. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Efficacy of low-dose intermittent interf

Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy

✍ Norio Akuta; Fumitaka Suzuki; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Yo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

## Abstract The efficacy of interferon (IFN) monotherapy for non‐responders to pegylated interferon (PEG‐IFN) plus ribavirin (RBV) combination therapy is still unclear. To evaluate the impact of IFN monotherapy on biochemical response, 200 consecutive patients infected with HCV genotype 1b, who rec

Serum hs-CRP was correlated with treatme

Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients

✍ Chung-Feng Huang; Ming-Yen Hsieh; Jeng-Fu Yang; Wu-Cheng Chen; Ming-Lun Yeh; Chi 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 193 KB